TBX21 and cancer: Based on regulon-level analysis of single-cell RNA-sequencing data, we found significantly lowered activity of the T-box TFs T-box 21 (TBX21) and eomesodermin (EOMES) in circulating CD8+ T cells and NK cells of the cancer-free TET2delA carriers.